Welcome to LookChem.com Sign In|Join Free
  • or
Pyridazine, 1,3-dichloro-1,2-dihydro- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

401564-64-5

Post Buying Request

401564-64-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

401564-64-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 401564-64-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,1,5,6 and 4 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 401564-64:
(8*4)+(7*0)+(6*1)+(5*5)+(4*6)+(3*4)+(2*6)+(1*4)=115
115 % 10 = 5
So 401564-64-5 is a valid CAS Registry Number.

401564-64-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-dichloro-pyridazine

1.2 Other means of identification

Product number -
Other names 2,6-dichloropyridazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:401564-64-5 SDS

401564-64-5Upstream product

401564-64-5Relevant academic research and scientific papers

Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors

-

, (2008/06/13)

This invention relates to novel sulfonyl pyridazinone compounds useful as aldose reductase inhibitors in the treatment or prevention of certain complications arising from diabetes mellitus, pharmaceutical compositions comprising the sulfonyl pyridazinone, pharmaceutical compositions comprising a combination of the sulfonyl pyridazinone together with a second pharmaceutical agent, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds, therapeutic methods comprising the administration of the sulfonyl pyridazinone compounds in combination with a second pharmaceutical agent and compounds useful as intermediates for preparing the sulfonyl pyridazinone compounds of this invention.

Therapies for tissue damage resulting from ischemia

-

, (2008/06/13)

This invention relates to therapeutic methods for treatment or prevention of tissue damage resulting from ischemia in mammals.

Sulfonyl pyridazinone compounds as therapeutic agents for ischemic tissue damage

-

, (2008/06/13)

This invention relates to therapeutic methods for treatment or prevention of tissue damage resulting from ischemia in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 401564-64-5